The Boston Consulting Group Announces Move to Tishman

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Boston Consulting Group Announces Move to Tishman Speyer's Pier 4 Development

BOSTON, MA--(Marketwired - Jun 27, 2016) - The Boston Consulting Group (BCG) , one of the world's leading management consulting firms, today announced plans to combine and relocate two Boston offices to Pier 4 in Boston's Seaport. By June 2018, BCG will move 700 employees into 202,000 square feet of space, approximately 7 floors, in the 13-story building being developed by Tishman Speyer.

BCG is the anchor tenant of the development, occupying more than half of the office space. Located at 200 Pier 4 Boulevard, near Northern Avenue, the Pier 4 office building will total 370,000 square feet. Neighbors in the Seaport district include GE, Fidelity Investments, PwC, and Goodwin Procter.

"We are excited to join our two offices in Boston as we move into the new Pier 4 location," said Simon Bartletta, a BCG senior partner and the managing director of the office at Exchange Place. "We see this new development as a great choice to support our dynamic organization and to position us for the future. With its sweeping views of the harbor and modern, new workspaces, this is a destination for attracting and developing our firm's most valuable asset: its people. We are thrilled to have the opportunity to design the space from scratch and encourage new ways of teaming to deliver the most value for our clients."

The building, by Elkus Manfredi Architects of Boston, will be built for LEED Gold certification. It will stand 13 stories high and offer commercial offices, on-site retail space, an expansive rooftop garden, a state-of-the-art fitness center, bicycle storage, and three levels of parking. Located a short distance from the Financial District, Pier 4 is surrounded by water on three sides and is served by multiple public transportation options including ferry and bus lines, with nearby access to I-93 and I-90.

"We search the globe for great locations in the best cities to develop new homes for world-class companies," said Rob Speyer, CEO of Tishman Speyer. "In the case of our Pier 4 development, we challenged ourselves to create an outstanding live-work-shop environment that would truly stand out within the exciting new community that is taking shape in the Boston Seaport district. We're very pleased that BCG shares our excitement for this very special place." 

Currently, BCG occupies 146,000 square feet of space at its two downtown office locations: Exchange Place and One Beacon. BCG has been a tenant at Exchange Place for 31 years and at One Beacon for 8 years. At Pier 4, BCG will occupy seven floors, 7 through 13.

"Our work processes have changed dramatically in recent years. Disruptive technologies have brought new opportunities for both virtual and physical collaboration, and an increasingly diverse workforce with new expectations is challenging us to continually innovate in our workplaces," said Kathryn Bell, a BCG partner and the managing director of the One Beacon office, who also is the partner responsible for BCG's global real estate.

 "Pier 4 gives us a unique opportunity to bring our workplace strategy to life, giving our people choice from among a rich variety of workspaces, and innovative technology to support productivity and simplify the work process. The ultimate goal is to shape a vibrant, enjoyable workplace experience, inspiring people to build relationships and share insights to deliver outstanding client value," Bell continued. 

Bartletta added, "We want this to be a place where employees want to spend time. It will be designed to enable and accelerate the development of innovative solutions and direct engagement with our clients, our nonprofit partners, our alumni, and the wider Boston community."

Employees will have access to the on-site fitness center and will be encouraged to enjoy the nearby public spaces, including a one-acre waterfront park and the Boston Harbor Walk, which is being extended onto the property by Tishman Speyer. Pier 4 will also be home to a nine-story, 100-unit luxury residential building next door, designed by internationally prominent SHoP Architects in collaboration with local Boston firm CBT. Each of the buildings will feature 17,000 square feet of ground floor retail space.

"The Boston Consulting Group is one of our leading businesses in the city, and I'm pleased that they have decided to continue to invest in their Boston presence," said Mayor Martin J. Walsh. "BCG's move to the Seaport district highlights the expansive and exciting growth Boston is undergoing, and I am excited to see BCG add to the thriving business environment in the Seaport."

In the lease transaction, Michael Joyce and John Barry of Transwestern RBJ represented BCG and Tishman Speyer's Sam Schaefer and Brooks Brown represented ownership. 

For more information on BCG's plans, please contact Alexandra Corriveau at corriveau.alexandra@bcg.com or 212-446-3261.

For more information on Pier 4, please contact Rick Matthews of Rubenstein Communications at rmatthews@rubenstein.com or 212-843-8267.

About The Boston Consulting Group The Boston Consulting Group (BCG) is a global management consulting firm and the world's leading advisor on business strategy. We partner with clients from the private, public, and not-for-profit sectors in all regions to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. Our customized approach combines deep insight into the dynamics of companies and markets with close collaboration at all levels of the client organization. This ensures that our clients achieve sustainable competitive advantage, build more capable organizations, and secure lasting results. Founded in 1963, BCG is a private company with 85 offices in 48 countries. For more information, please visit bcg.com .

About Tishman Speyer Tishman Speyer is a leading owner, developer, operator and fund manager of first-class real estate around the world. Founded in 1978, Tishman Speyer is active across the United States, Europe, Latin America and Asia, building and managing premier office, residential and retail space in key global markets for industry-leading tenants. The firm has acquired, developed and operated a portfolio approximately 140.1 million square feet with a total value of approximately US$76.1 billion spread over 276 investments involving 380 properties. Signature assets include New York City's Rockefeller Center and Chrysler Center, São Paulo's Torre Norte, The Springs in Shanghai and OpernTurm in Frankfurt. Tishman Speyer currently has projects at different stages of development in Atlanta, Boston, Brasília, Chengdu, Frankfurt, Gurgaon, Hyderabad, Los Angeles, New York City, Paris, Rio de Janeiro, San Francisco, São Paulo, Shanghai, Suzhou and Washington, DC.

For more information on BCG's plans, please contact Alexandra Corriveau corriveau.alexandra@bcg.com 212-446-3261 For more information on Pier 4, please contact Rick Matthews Rubenstein Communications rmatthews@rubenstein.com 212-843-8267

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LONGi's Four Paths to Global Green Development

Updated Category News Views 62

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 149

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 469

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 92

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

AAVantgarde's Professor Auricchio Receives Prestigious Role

Updated Category News Views 177

AAVantgarde's Professor Auricchio Achieves New Milestone MILAN, a milestone moment has arrived for AAVantgarde Bio as Professor Alberto Auricchio, the visionary Founder and Chief Scientific Officer, has been elected President of the European Society of Gene and Cell Therapy. This prestigious appointment recognizes his exceptional contributions and unwavering commitment to...

Continue Reading
How Bitcoin's Drop Affects Strategy Inc (NASDAQ: MSTR) Investors

Updated Category News Views 137

Understanding the Current Market Landscape As recent market trends demonstrate, Strategy Inc (NASDAQ: MSTR) is seeing significant activity. On one hand, the company is evidently reliant on the performance of Bitcoin. With such dependence, the fluctuations in the value of Bitcoin are crucial to the health of MSTR. This situation poses both risks and opportunities for...

Continue Reading
Significant Attorney Departures to Strengthen Association Law Firm

Updated Category News Views 99

Major Attorney Moves to Association Law Group (ALG) In a noteworthy shift within Florida's community association law landscape, several prominent attorneys have transitioned from Becker & Poliakoff to join the ranks of Association Law Group (ALG). Among them, Michael C. Gongora, Lilliana Farinas-Sabogal, and Adam Cervera are recognized for their extensive experience in...

Continue Reading
EQB's Commitment to Sustainability in Financial Services

Updated Category News Views 175

EQB Focuses on Sustainability in Its Latest Report EQB Inc. (TSX: EQB) has recently published a detailed Responsibility Report, highlighting significant strides towards its sustainability commitments. This annual report encapsulates the company's dedication to fostering an environment of innovation within the Canadian banking sector, with a particular focus on enriching...

Continue Reading
BofA's Downgrade of Sandvik: Navigating Market Pressures Ahead

Updated Category News Views 103

BofA Securities dropped a bomb on Sandvik AB back then by downgrading it from Neutral to Underperform. This move sent shockwaves through the trading floor, mainly because they saw some serious trouble brewing in Sandvik’s Machining and Manufacturing Solutions (SMMS) division. Traders were quick to pick up on the whispers about short cycle pressures that could really...

Continue Reading